CDSCO UID IMP/IVD/2023/000221_23acfddc2be563545c9c94003d157640_8e170f43188776631b75c0b219d20a6b

STart Max

Q-Line Biotech Private Limited·Device Class Class A·India CDSCO·Brand: STart Max
Registration details
UID
IMP/IVD/2023/000221_23acfddc2be563545c9c94003d157640_8e170f43188776631b75c0b219d20a6b
Device class
Class A
Brand name
STart Max
Approving authority
CDSCO
Product information
The STart Max is a semi-automatic clinical analyzer intended to be used with disposables and reagent products by professional laboratory personnel for qualitative and/or quantitative in vitro determination and to perform clotting tests on human blood samples the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.
Other products from Q-Line Biotech Private Limited
Products from the same license holder (10 products)
HIV 4th Generation
Brand: Q-LISA
Class C
Syphilis ELISA Test
Brand: Q-LISA
Class C
HIV-Ab/Ag 4th Gen
Brand: Q-LISA
Class C
Automated ESR Analyzer
Brand: Microsed- System® ESR Analyzer
Class A
Elisa Strip Reader
Brand: Stat-Fax
Class A
Auto-Chemistry Analyzer
Class A
Auto Chemistry Analyzer
Class A
Semi Auto Urine Analyzer
Brand: Uriscan
Class A
Urine Analyzer
Brand: Uriscan
Class A
Fully Automated Urine Analyzer
Brand: Uriscan
Class A
About this record

STart Max is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000221_23acfddc2be563545c9c94003d157640_8e170f43188776631b75c0b219d20a6b. This device is marketed under the brand name STart Max. The license holder is Q-Line Biotech Private Limited, and it is classified as Device Class Class A. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.